Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

DiCE Molecules
279 E. Grand Avenue, Suite 300, Lobby B
South San Francisco, CA 94080
Phone: 650-566-1402
http://www.dicemolecules.com/

DiCE Molecules is a biotechnology company utilizing its proprietary DNA-encoded library (DEL) technology, combined with unique structural insights, to generate small molecule antagonists against a range of protein-protein-interface (PPI) targets.

Key Contact
Name
Kevin Judice
Title
CEO
Funding Events

Date
Amount
Type
Investors
01/08/21 $80,000,000 Series C Alexandria Venture Investments
Altitude Life Sciences Ventures
Asymmetry Capital Management
Driehaus Capital Management
Eventide Asset Management
New Leaf Venture Partners
Northpond Ventures
Osage University Partners
RA Capital Management
Sands Capital
Sanofi Ventures
Soleus Capital